Pages that link to "Q38027604"
Jump to navigation
Jump to search
The following pages link to Guidelines for treatment of atopic eczema (atopic dermatitis) Part II. (Q38027604):
Displaying 50 items.
- Oral H1 antihistamines as ‘add-on’ therapy to topical treatment for eczema (Q24185954) (← links)
- Emollients and moisturisers for eczema (Q24186075) (← links)
- Effects of systemic immunosuppressive therapies for moderate-to-severe eczema in children and adults (Q24188221) (← links)
- Psychological and educational interventions for atopic eczema in children (Q24201204) (← links)
- Complementary and alternative medicine treatments for atopic eczema (Q24201373) (← links)
- S2k guideline on diagnosis and treatment of atopic dermatitis — short version (Q26744978) (← links)
- Nonsteroidal Topical Immunomodulators in Allergology and Dermatology (Q26752832) (← links)
- Management of atopic dermatitis: safety and efficacy of phototherapy (Q26778443) (← links)
- Atopic dermatitis and skin allergies - update and outlook (Q26851924) (← links)
- Systemic therapy for atopic dermatitis (Q27005835) (← links)
- The diagnosis and graded therapy of atopic dermatitis (Q27025032) (← links)
- The Long-Term Course of Atopic Dermatitis (Q30234105) (← links)
- Sublingual immunotherapy: World Allergy Organization position paper 2013 update (Q30440195) (← links)
- Computational design of treatment strategies for proactive therapy on atopic dermatitis using optimal control theory (Q33694845) (← links)
- Spotlight on dupilumab in the treatment of atopic dermatitis: design, development, and potential place in therapy (Q33713754) (← links)
- Improved efficacy of allergen-specific immunotherapy by JAK inhibition in a murine model of allergic asthma (Q33752141) (← links)
- Use of emollients in atopic dermatitis: a questionnaire survey study (Q34054436) (← links)
- Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis (Q34388802) (← links)
- Therapeutic strategies in extrinsic atopic dermatitis: focus on inhibition of IL-4 as a new pharmacological approach (Q34441795) (← links)
- Target-oriented therapy: Emerging drugs for atopic dermatitis (Q34510687) (← links)
- Omalizumab in children (Q34604574) (← links)
- Mapping systematic reviews on atopic eczema--an essential resource for dermatology professionals and researchers (Q34625848) (← links)
- Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies (Q35077866) (← links)
- Alpine climate treatment of atopic dermatitis: a systematic review (Q35226555) (← links)
- Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents (Q35539576) (← links)
- Guidelines of care for the management of atopic dermatitis: Section 4. Prevention of disease flares and use of adjunctive therapies and approaches (Q35603170) (← links)
- Allergen-Specific Immunotherapy with Monomeric Allergoid in a Mouse Model of Atopic Dermatitis. (Q35746514) (← links)
- Chitosan Coated Textiles May Improve Atopic Dermatitis Severity by Modulating Skin Staphylococcal Profile: A Randomized Controlled Trial (Q35855543) (← links)
- Genome-wide association study of recalcitrant atopic dermatitis in Korean children (Q36037543) (← links)
- Atopic dermatitis: current treatment guidelines. Statement of the experts of the Dermatological Section, Polish Society of Allergology, and the Allergology Section, Polish Society of Dermatology. (Q36048469) (← links)
- Effects of Angelicae dahuricae Radix on 2, 4-Dinitrochlorobenzene-Induced Atopic Dermatitis-Like Skin Lesions in mice model (Q36273350) (← links)
- Assessing United States Patient and Dermatologist Experiences with Severe Chronic Hand Eczema (Q36399482) (← links)
- Clinical Features of Adult/Adolescent Atopic Dermatitis and Chinese Criteria for Atopic Dermatitis (Q36760937) (← links)
- Skin-protective effects of a zinc oxide-functionalized textile and its relevance for atopic dermatitis (Q36851352) (← links)
- Off-label prescribing for allergic diseases in children (Q37592152) (← links)
- Translating translation into patient benefit for atopic eczema (Q37593739) (← links)
- TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for an international Delphi exercise to identify a core set of domains and domain items for national atopic eczema registries (Q37671365) (← links)
- Systemic Treatment of Adult Atopic Dermatitis: A Review. (Q37679948) (← links)
- Comparing high altitude treatment with current best care in Dutch children with moderate to severe atopic dermatitis (and asthma): study protocol for a pragmatic randomized controlled trial (DAVOS trial). (Q37683800) (← links)
- Update in clinical allergy and immunology. (Q38056516) (← links)
- Pimecrolimus for psoriasis. (Q38086585) (← links)
- Pimecrolimus, a topical calcineurin inhibitor used in the treatment of atopic eczema. (Q38123240) (← links)
- Functional textiles for atopic dermatitis: a systematic review and meta-analysis (Q38131812) (← links)
- Photo(chemo)therapy in the management of atopic dermatitis: an updated systematic review with implications for practice and research (Q38151742) (← links)
- Methotrexate for treatment of atopic dermatitis in children and adolescents (Q38193907) (← links)
- Recent advances in paediatric dermatology (Q38202032) (← links)
- Evidence - based pharmacological treatment of atopic dermatitis: an expert opinion and new expectations (Q38202096) (← links)
- Clinical pearls from atopic dermatitis and its infectious complications (Q38203586) (← links)
- Atopic dermatitis - all you can do from the outside (Q38203595) (← links)
- Immunological and molecular targets of atopic dermatitis treatment (Q38203601) (← links)